Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/25 17:37 | 1/15/25 | NKTX | Health | Drug | Pharmaceutical Preparations | Shook David | CA | O | See Rema | 1 | S | -19 | 2.20 | 0 | -9 | 191 | D | |||||||||||||||
1/17/25 17:36 | 1/15/25 | NKTX | Health | Drug | Pharmaceutical Preparations | Levin Alyssa | CA | O | See Rema | 1 | S | -13 | 2.20 | 0 | -6 | 103 | D | |||||||||||||||
1/17/25 17:36 | 1/15/25 | NKTX | Health | Drug | Pharmaceutical Preparations | Brandenberger Ralph | CA | O | Chief Te | 1 | S | -16 | 2.20 | 0 | -7 | 125 | D | |||||||||||||||
1/17/25 17:35 | 1/15/25 | NKTX | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | 1 | S | -38 | 2.20 | 0 | -17 | 320 | D | |||||||||||||||
1/17/25 17:35 | 1/15/25 | NKTX | Health | Drug | Pharmaceutical Preparations | Hager Alicia J. | CA | O | GC | 1 | S | -21 | 2.20 | 0 | -10 | 147 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |